Search Results

Continuous erythropoiesis receptor activator (CERA).

• Authors : O'Mara, Neeta Bahal; Kapolan, Toros

Subjects: CHRONIC kidney failure; ERYTHROPOIESIS; ERYTHROPOIETIN

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p233-244. 10p.

Record details

Subanalysis Supports Imetelstat for Transfusion-Dependent Low-to Intermediate-1--Risk MDS.

• Authors : SCOTT, RYAN

Subjects: MYELODYSPLASTIC syndromes treatment; BLOOD transfusion; ERYTHROPOIESISSEKERES, Mikkael A.

• Source: OncologyLive; Aug2024, Vol. 25 Issue 10, p10-11, 2p

Record details

ESA warnings riling practice.

• Authors : Magill-Lewis, Jilene

Subjects: *PHYSICIANS; *WARNING labels; *PRODUCT safetyUNITED States. Food & Drug Administration

• Source: Drug Topics. 4/16/2007, Vol. 151 Issue 8, HEALTH-SYSTEM EDITION pHSE1-HSE1. 1p.

Record details

Higher target hemoglobin levels put one at greater risk.

Subjects: *MEDICAL care; *HEALTH care industry; ERYTHROPOIESISUNITED States. Food & Drug Administration

• Source: Drug Topics. 12/11/2006, Vol. 150 Issue 23, p8-8. 1/4p.

Record details

Erythropoiesis-stimulating agents for anemia in older adults.

• Authors : Dharmarajan, T. S.; Widjaja, David

Subjects: ERYTHROPOIETIN; DRUG efficacy; ANEMIA treatment

• Source: Formulary. Aug2008, Vol. 43 Issue 8, p297-303. 6p.

Record details

Novel erythropoiesis-stimulating protein: an erythropoietin analogue with an extended half-life and less frequent dosing.

• Authors : Joy MS

• Source: Formulary; Jan2001, Vol. 36 Issue 1, p19-25, 7p

Record details

Erythropoiesis- Stimulating Protein Support and Survival.

• Authors : Crawford, Jeffrey

• Source: Oncology (08909091); Jul2006 Supplement, Vol. 20, p39-43, 5p, 3 Charts, 2 Graphs

Record details

Benefits of Early Intervention With Erythropoiesis- Stimulating Proteins in Chemotherapy- Induced Anemia.

• Authors : Lyman, Gary H.

• Source: Oncology (08909091); Jul2006 Supplement, Vol. 20, p16-20, 5p, 2 Charts, 1 Graph

Record details

Risks and Realities of REMS.

• Authors : Wechsler, Jill

Subjects: RISK assessment; DRUG development; CANCER treatmentUNITED StatesUNITED States. Food & Drug Administration

• Source: Pharmaceutical Technology; Apr2010, Vol. 34 Issue 4, p28-36, 5p

Record details

Safety labeling updates & new warnings.

Subjects: MEDICAL prescriptions; PHARMACEUTICAL policy; DRUG labelingUNITED States

• Source: Formulary. Apr2007, Vol. 42 Issue 4, p218-218. 1/3p.

Record details